Skip to main content Skip to section navigation Skip to footer
Careers Resources Contact
Codexis, Inc.
  • Home
  • About Us
    • Overview
    • Social Responsibility
    • News
    • Events
    • History
    • Management Team
    • Board of Directors
  • Focus Areas
    • Overview
    • Biotherapeutics
    • Life Sciences
    • Pharmaceutical Manufacturing
  • Technology
  • Products
    • Overview
    • Life Science Enzymes
    • Biocatalysts
  • Partnerships
    • Overview
    • Discovery and Development
    • Scale-up and Supply
    • Our Partners
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Resources
  • Contact
  • Search

Press Releases at Codexis

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 15, 2021 8:00am EST

Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th International Congress of Inborn Errors of Metabolism 2021

Nov 15, 2021 8:00am EST

Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development

Nov 09, 2021 4:05pm EST

Codexis to Participate in Upcoming Virtual Healthcare Conferences

Nov 04, 2021 4:05pm EDT

Codexis Reports Third Quarter 2021 Financial Results

Nov 04, 2021 8:00am EDT

The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.

Nov 03, 2021 4:05pm EDT

Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

Oct 21, 2021 4:05pm EDT

Codexis to Report Third Quarter 2021 Financial Results on November 4

Oct 18, 2021 8:00am EDT

Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India

Sep 09, 2021 4:05pm EDT

Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin

Sep 07, 2021 4:05pm EDT

Codexis to Participate in Upcoming Virtual Healthcare Conferences

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …18
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Twitter Linkedin
  • Sitemap
  • Terms of Sale
  • Trademarks
  • Patents
  • Terms of Use
  • Privacy
  • Disclaimer
©2023 Codexis, Inc. All Rights Reserved.